N
Nautilus
Delivering a high-throughput, low-cost platform for analyzing and quantifying the human proteome
About Nautilus
Nautilus Biotechnology operates in the biotechnology sector, focusing on proteomics, which is the large-scale study of proteins. The company has developed an advanced platform designed to accelerate the drug development process by providing researchers with deep insights into the roles of drug targets in health and disease. This platform aims to make it easier to prioritize drug targets with high potential for clinical success, thereby reducing inefficiencies and costs associated with traditional drug discovery methods. Nautilus Biotechnology serves pharmaceutical companies, research institutions, and biotech firms, offering them a tool to enhance their research capabilities and improve clinical outcomes. The business model is primarily B2B (business-to-business), generating revenue through the sale of its proteomics platform and related services. By unlocking the proteome, Nautilus aims to fuel breakthroughs in basic biology, medicine, and biotechnology, ultimately impacting global health positively.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Listing
- Public via SPAC 2021
Open roles
Nautilus in the Seattle ecosystem
The Nautilus office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A8 investors entered at this stage
Cercano Management
Andreessen Horowitz
Perceptive Advisors
AME Cloud Ventures
Defy Partners
Bolt Ventures
Bezos Expeditions
Madrona Venture Group
Series B and later7 investors entered at this stage
Casdin Capital
OrbiMed
Franklin Templeton Investments
Bain Capital Life Sciences
RA Capital Management
Ally Bridge Group- AIArya Sciences Acquisition III
Source: Dealroom Talent Intelligence.
Patents
19 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
See Nautilus on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
Nautilus wins up to $6M in ARPA-H grant to probe Alzheimer’s and cancer proteins
Gainline closes oversubscribed continuation fund for Core Health & Fitness, led by StepStone